Increase in hematoma volume (HV) in the brain after intracerebral hemorrhage (ICH) is a major cause of worsening clinical condition, and is an independent predictor for mortality and outcome. Our goals were to evaluate the relationship between subclinical, clinical factors to change intracerebral HV in acute supratentorial hemorrhage in first 72 hours after onset.
Trang 1EVALUATION OF RELATIONSHIP BETWEEN TESTS, CLINICAL FACTORS TO CHANGE INTRACEREBRAL Hematoma Volume
IN ACUTE SUPRATENTORIAL HEMORRHAGE
Dinh Vinh Quang*; Nguyen Van Chuong**
summary
Increase in hematoma volume (HV) in the brain after intracerebral hemorrhage (ICH) is a major cause of worsening clinical condition, and is an independent predictor for mortality and outcome Our goals were to evaluate the relationship between subclinical, clinical factors to change intracerebral
HV in acute supratentorial hemorrhage in first 72 hours after onset
Descriptive, prospective analysis of 188 acute supratentorial hemorrhage patients associated with hypertension at admission, admitted within six hours after onset, from 2010 to 2013
Results: The average age was 58.2, including 128 males (68%) and 60 females (32%) Univariate analysis showed that 9 important factors related to increased HV were: (1) Glasgow on admission, (2) NIHSS on admission, (3) Rankin at admission, (4) SBP at admission, (5) Hematoma volume, (6) Shape of hematoma, (7) Spot sign, (8) WBC, and (9) Glycemie Multivariate analysis showed that two independent prognostic factors associated with increasing HV were: (1) The shape of the hematoma is irregular on CT, and (2) Spot sign on CTA
* Key words: Acute supratentorial hemorrhage; Subclinical, clinical factors.
INTRODUCTION
Stroke, one of the causes of death in
neurological diseases, or prolonged sequelae
and disabilities, is a common disorder
Intracerebral hemorrhage (ICH) accounted
for 15 to 20% of stroke, causing death or
severe disability more than cerebral infarction
[3] In ICH appeared, risk factors, hypertension
and cerebral amyloid angiopathy accounted
for 78-88% [2]
When ICH appears, there are some
factors affecting to clinical status of the
patient (PT) An increase in HV in the brain
after ICH is a major cause worsening
clinical condition and is an independent
predictor for mortality and outcome [8]
Identifying the factors that increase HV(HV) after ICH is important in the treatment and prognosis of ICH patients In the acute ICH phase, if hypertension uncontrolled can increase the risk of continuous bleeding or re-bleeding, increased HV For the treatment and better care of ICH patients in the early hours, we performed this study, aiming to: Evaluate the relationship between tests, clinical factors to change intracerebral HV in acute supratentorial hemorrhage in first 72 hours after onset
Subjects and Methods
1 Subjects
associated with hypertension, admission before
* 115 Hospital
** 103 Hospital
Address correspondence to Dinh Vinh Quang: 115 Hospital
E.mail: quanghung115@yahoo.com.vn
Trang 2six hours after onset, treated at Department
of Cerebral-Vascular Pathology, 115 People
Hospital from 1 - 2011 to 4 - 2013 agreed with
enrollment in the study Inclusion criteria will
be included in the study
* Inclusion criteria:
ICH is the first acute supratentorial
hemorrhage (STH) associated with hypertension
at admission, admitted within six hours after
onset Brain images on computerized
tomography (CT) help diagnose supratentorial
hemorrhage
Hypertension diagnostic criteria (the JNC
VII): The systolic blood pressure (SBP) higher
than 140 and/or diastolic blood pressure (DBP)
higher than 90 mmHg
* Exclusion criteria:
- Supratentorial hemorrhage (STH) due to
aneurysm rupture, arteriovenous malformations,
moyamoya disease, by using anticoagulants
or anti-platelet drugs
-.STH wi th blood intra ve ntricul ar
(intraventricular hemorrhage)
- Patients died before the second CT.Scan
shot
- STH transformation of cerebral infarction
- Renal failure, creatinine ≥ 1.7 mg/dl
- A history of allergy to contrast drugs
2 Research methodology
Study design: descriptive, prospective
analysis, univariate regression and multivariate
3 Data collection
- The clinical data: age, gender, time from
onset to hospitalization, history of hypertension,
diabetes, heart disease, liver disease, smoking,
drinking, time of onset, the symptoms onset
+ BP, consciousness at admission, paralysis
of cranial nerve VII, strength of the arms
and legs paralyzed
+ Glasgow, NIHSS, Rankin at admission and 72 hours after onset
+ BP at 6 hour, then BP measurement every 4 hours to 72 hours after stroke
- Tests data:
+ Take unenhanced CT at admission + Blood tests: Red blood cells (RBC), hemoglobin (Hb), hematocrit (Hct), white blood cells (WBC), platelet count (PTC), glycemie, total cholesterol, LDL-cholesterol, HDL-cholesterol, triglyceride, liver function tests (AST, ALT-aspartate aminotransferase, alanine aminotransferase), renal function (bun, creatinine), PT (prothrombin time), APTT (activated partial thromboplastin time), fibrinogen, INR
+ Brain CT-angiography (CTA) in the first
24 hours after onset
+ Take the second unenhanced CT as clinical status worsen (Glasgow score decreased from two points or more) or 72 hours after stroke
4 Assessment criterial
- STH status of patients after 72 hours was evaluated in two groups: blood volume without increase and increase (enlargement)
HV in the brain increases under Kazui [16]
as V2 - V1 ≥ 12.5 cm3 or V2/V1 ≥ 1.4, where V1, V2 respectively HV on brain CT-scan 1st and 2nd time
- HV calculated by Kothari,s formular (or Broderich): V = (A x B x C)/2 Where A, B, C are the largest three diameter perpendicular
to each other in three dimensions of the hematoma
- Find the factors affecting changes HV
of STH in the first 72 hours after admission
by means of univariate regression analysis
- After univariate analysis, the significant important variables in univariate analysis will
be included in a multivariate regression analysis
Trang 3to find the binary logistic variable prognostic
value after adjustment by other variables
and evaluate odds ratio OR (odds ratio)
Results and discussion
1 General characteristics of the study
group
- Age: mean age: 58.29, similar to the
common age for stroke in general
- Gender: 188 patients, including 128 males
(68.08%) and 60 females (31.91%), ratio
between men and women was 2:1
- The onset period and admission: average
4.03 hours, of which, 10 patients (5.3%) in
the first hour, 76 patients (40.4%) in 3 hours
2 The risk factors
Figure 1: The risk factors of stroke
patients with STH
Patients with history of hypertension are
4 times as many as those without history of
hypertension In the study group, most patients
had no history of liver disease, heart disease
and stroke before ICH
In comparing the two groups of increase
and non-increase HV in patients with history
of non-and hypertension, diabetes, heart
disease, liver disease, smoking, alcohol
drinking, we found no difference between
the two groups with p value of 0.78, 1.00, 1.00, 1.00, 0.75, 0.59 respectively
3 The clinical factors and test
- Symptoms at onset:
+ There is no difference in symptoms at onset such as dizziness, headache, vomiting, seizures, speech disorders between two groups of increase and non-increase HV with p value of 0.75, 0, 45, 0.059, 1.00, and 0.13 respectively
+ Rate enlargement HV in patients with paralysis on the left (70.83%) was significantly higher than the right side paralyzed patients (29.17%), this difference was statistically significant with p = 0.043
+ Consciousness:
Enlargement HV rate in patients with glasgow 13 - 15, 9 - 12, ≤ 8 score at admission were 72%, 22% and 6% respectively It was noted that enlargement HV rate was different between groups of conscious disorder at admission (p = 0.04)
+ There is a difference in scores of neurological symptoms at admission assessed
by Glasgow, NIHSS, mRS scales in both groups
of increase and non-increase HV This difference
is statistically significant with a p value of 0.02, 0.02, and 0.03 respectively
Table 1: Comparison of neurological scales
between the two groups of increase and non-increase in HV
At admission
non increase
value
Trang 4- Blood pressure:
When comparing the mean blood pressure
between the groups with and without increased
HV, we realized significant differences in
blood pressure between the two groups, the
SBP, DBP and MAP
Table 2: Comparison of blood pressure
between the two groups increased and did
not increase hematoma volume
p value
In the first 72 hours, the group increased
HV had average SBP > 140 mmHg compared
with the group of non-increase HV (average
SBP < 140 mmHg), this difference was
statistically significant (p = 0.0016) In a
study by Fujii [10], the results showed
enlargement HV rate increased significantly
with higher values SBP after admission,
the rate of HV increase in patients with
SBP < 145 mm Hg, 145 - 160 mm Hg,
> 160 - 175 mmHg, and ≥ 175 mmHg, 6.5%,
13.0%, 14.1%, and 21.7% respectively
- Characteristics of hematoma on CT:
+ HV on 2nd CT compared with 1st CT:
Figure 2: V1, V2 is HV on 1st and 2nd CT taken
at admission and 2nd time
(Sources: CT-scans of 1 patient in this study)
Figure 3: HV on 1st and 2nd CT of patients
In 188 patients, we recorded 24 patients (12.77%) with an increase in HV (enlargement cerebral hemorrhage), 164 patients (88.23%) without an increase when compared to HV
on CT.Scan 2nd to 1st, similar to the study
by Fujii et al: 14.0% and other studies : increased HV rate of 3% [5], 7% [9], 14% [10] Time blood continues to flow after ICH undetermined Bleeding time in ICH is usually supposed to end from a few minutes to an hour Fujii et al [11] studied 419 patients
Trang 5with ICH, taken CT-scan within the first 24
hours after onset and the second within 24
hours of admission, 60 patients (14.3%) on
the 2nd CT increase HV The authors noted
that increased HV rate decreases over time
Some other studies showed that blood flow
may still continue and last longer than 6
hours after onset [7, 9]
- Location of hematoma on brain CT:
There were significant differences in the
rate of hematoma location between groups
divided according to location as follows:
82.98% basal ganglia, 2.66% capsule, 9.04%
thalamus, 5.32% brain lobes Over 85% of
patients had putamen hemorrhage Compared
with other studies, in a study by Nguyen
Minh Hien (1995) [1], the rate of putamen
hemorrhage was 48%, Nguyen Van Dang
(1997) was 50%, Duc Kiet Hoang with rate of
the capsule-striatum hemorrhage was 47.1%,
Nguyen Lien Huong: 38.6% In a study by
Matthew L.Flaherty (2005) in Kentucky-North
America, the rate of capsule - putamen
hemorrhage was 49% Although the significant
difference in hematoma location between
groups of patient was classified according to
location as above, there was no significant
difference in enlargement rate between
the groups hematoma location in the lobes,
basal ganglia, capsule and thalamus
(p = 0.26) This result was similar to the
study by Fujii [10]
- Shape of hematoma on the brain CT:
Ratio of enlargement hematoma in group
of irregular hematoma shape (10/22) was
significant higher than group of regular
hematoma shape (14/166) (p = 0.000) This
result is similar to the study by Fujii [10]
Figure 4: Shape of hematoma on the brain
CT (Source: CT at admission and second
of 1 patients in this study)
- HV on the first CT:
The relationship between increased HV and HV was shown examining in 188 STH patients HV increased in 20.83% of patients with HV small (< 15 cm3), 29.17% in those with moderate HV (15 - 29 cm3), 16.67% in those with big hematoma (30 - 45 cm3), and 33.33% in those with large hematoma (> 45 cm3) Enlargement HV rate increased significantly with an increase in blood volume
in the series first CT This result is similar to the study by Fujii [10]
- Time CTA:
Ratio of enlargement hematoma in group
of patients with time from onset to take the CTA < 6 hours, 6 - 12 hours before, 12 - before
Trang 618 hours, 18 - 24 hours: 34.78%, 30.43%,
0.0% and 34.78%, respectively Ratio of
enlargement hematoma in groups with
different times taken CTA did not differ
statistically significant (p = 0.12)
- Spot sign: Image of contrast drug
extravasation (spot sign) on brain CTA:
After ICH, the contrast brain CT scan
and/or CT.Angiography (CTA) in the early
hours, we can see image of contrast drug
extravasation and left in hematoma, the
predicted sign blood still continues to flow, which can identify the risk of increased
HV [6]
The results of our study revealed increased
HV in 18 of 168 patients without spot sign (75%), 6 of 20 patients with a spot sign (25%) When univariate analysis, this difference
is statistically significant (p = 0.005) The result is similar to the study by Ryan Wada (p = 0.0001), and E Josser Delgado Almandoz (p < 0.0001)
Figure 5: Spot sign on the CTA
(Source: CT at admission, CTA and CT 2nd times of 1 patient in this study)
- The test parameters:
Table 3: Comparison of the indices between the two groups of increase and
non-increase in HV
Trang 7(1) (2) (3) (4)
White blood cell count and glycemie levels
in patients with increased HV was higher in
patients without increased HV, this difference
is statistically significant (p = 0.033) and
0.027 Similar results in the study of Kazui
and colleagues found that glycemie at
admission ≥ 141 mg/dl is a risk factor of
increasing HV According to Fisher CM
(1971), glycemie at admission ≥ 200 mg/dl
will aggrevate the clinical condition of the
ICH patient in the acute phase [4]
Univariate analysis above showed that
the presence of 14 factors related to
increased HV, of which, 9 were important
factors related to increased HV such as:
(1) Glasgow at admission, (2) NIHSS at
admission, (3) Rankin at admission, (4) SBP
at admission, (5) HV, (6) shape of hematoma,
(7) spot sign, (8) WBC and (9) glycemie
- Multivariate analysis of factors affecting
increase HV:
Our multivariate regression analysis
presented independent predictors of
increased HV Univariate analysis also
showed the presence of 14 factors related
to increased HV, which we picked out 9 key factors related to increased HV for inclusion
in multivariate analysis with the dependent variable of increased HV
Table 4: Multivariate analysis of factors
affecting the increase HV
Glasgow at
NIHSS at
Rankin at
SBP at
Shape of
Trang 8Results of multivariate analysis showed
that two independent prognostic factors with
increasing HV are: (1) the shape of the
hematoma is irregular on CT (OR = 0.19,
p = 0.005), and (2) Spot sign on CTA (OR =
2.41, p = 0.044)
In this study, we identified two prognostic
factors that independently increased HV
are: (1) the shape of the hematoma is
irregular on CT, and (2) Spot sign on CTA
Compared with previous studies, those by
Fujii [10], in addition to the shape of the
hematoma is irregular on CT factor, this
author also recorded 4 other factors with
independent prognostic HV increase including:
(1) time from onset to admission early (before
6h), (2) the amount of alcohol consumed
during the day, (3) consciousness disorders
at admission, and (4) low fibrinogen levels
As for spot sign, our results are similar to
two studies by Ryan Wada and Josser E,
Delgado Almandoz that signals spot is an
independent prognostic factor for the increase
in HV
Conclusion
Through a prospective study of 188 STH
patients with hypertension at admission, we
draw some conclusions:
- Average age: 58 years old, men were
twice as many as women
- The time between stroke onset and
hospitalization was 4 hour on average, only
5.3% during the first hour, 40.4% at 3 hours
- Average HV on 2nd CT was 26.54 cm3,
1st CT was 22.35 cm3 89.36% of patients
had regular hematoma shape, 10.64% had
irregular hematoma shape, over 85% of
STH located in the basal ganglia and capsule
- 10.64% of STH patients had the spot sign on CTA
- Rate of increased HV on 2nd CT after
72 hours was 12.77% when compared with
1st CT
- Univariate analysis showed that 9 important factors related to increased HV are: (1) Glasgow at admission, (2) NIHSS at admission, (3) Rankin at admission, (4) SBP at admission, (5) hematoma volume, (6) shape of hematoma, (7) spot sign, (8) WBC and (9) glycemie
- Multivariate analysis showed that two independent prognostic factors related to
an increase in HV: (1) the shape of the hematoma was irregular on CT (OR = 0.19,
p = 0.005) and (2) spot sign on CTA (OR = 2.41, p = 0.044)
REFERENCES
1 Nguyen Minh Hien Some of clinical features
and Siriraj diagnostic scale in disting uish supratentorial cerebral infarction Journal of Neurology 2003, 4, pp.52-55
2 Vu Anh Nhi Thần kinh học Department of Neurology Medical University Hochiminh City Medical Publisher 2003
3 Anderson CS, Jamrozik KD, Broadhurst
RJ, Stewart-Wynne EG Predicting survival for
1 year among different subtypes of stroke: results from the Perth Community Stroke Group Stroke
1994, 25, pp.1935-1944
4 Badjatia N, Rosand J Intracerebral
hemorrhage The Neurologist 2005, 11 (6), pp.311-324
Trang 95 Bae HG, Lee KS, Yun IG, et al Rapid
expansion of hypertensive intracerebral hemorrhage
Neurosergery 1992, 31 (1), pp.35-41
6 Becker KJ, Baxter AB, Bybee HM,
Tirschwell DL, Abouelsaad T, Cohen WA
Extravasation of radiographic contrast is an
independent predictor of death in primary
intracerebral hemorrhage Stroke 1999, 30,
pp.2025-2032
7 Chen ST, Chen SD, Hsu CY, Hogan EL
Progression of hypertensive intracerebral hemorrhage
Neurology 1989, 39, pp.1509-1514
8 Davis SM, Broderick J, Hennerici M, Brun
NC, Diringer MN, Mayer SA, Begtrup K, Steiner
T Activated recombinant factor VII intracerebral
hemorrhage trial investigators Hematoma growth
is a determinant of mortality and poor outcome
after intracerebral hemorrhage Neurology 2006,
66, pp.1175-1181
9 Fehr MA, Anderson DC Incidence of
progression or rebleeding in hypertensive
intracerebral hemorrhage Stroke Cerebrovascular
Dis 1991, 1, pp.111-116
10 TR Fujii Y, Takeuchi S, Minakawa T,
Sasaki O Multivariate analysis of hematoma
enlargement in spontaneous intracerebral
hemorrhage Stroke 1998, 29, pp.1160-1166